Your browser doesn't support javascript.
Cytokine Storm and Immunomodulation in COVID-19.
Rangappa, Pradeep.
  • Rangappa P; Department of Critical Care Medicine, Columbia Asia, Bengaluru, Karnataka, India.
Indian J Crit Care Med ; 25(11): 1288-1291, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1512930
ABSTRACT
COVID-19 has become a major pandemic in recent times. The exact pathophysiology and understanding of cytokine storm and immunomodulation are evolving. Various cytokines have been implicated in the pathophysiology of COVID-19. Immunosuppressant immunomodulators like steroids, canakinumab, anakinra, tocilizumab, sarilumab, baricitinib, ruxolitinib, bevacizumab, and itolizumab have been tried. Immunostimulant immunomodulators like interferons (IFNs) and Mycobacterium w (Mw) have also been repurposed. Considering the role of multiple cytokines implicated in COVID-19, molecules working on the majority of the targets, may hold a promising future prospect. HOW TO CITE THIS ARTICLE Rangappa P. Cytokine Storm and Immunomodulation in COVID-19. Indian J Crit Care Med 2021;25(11)1288-1291.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Indian J Crit Care Med Year: 2021 Document Type: Article Affiliation country: Jp-journals-10071-24029

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Indian J Crit Care Med Year: 2021 Document Type: Article Affiliation country: Jp-journals-10071-24029